Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion

Authors

Institutions

Publication Details

Journal
Diabetes Therapy
Published
2025-06-18
DOI
https://doi.org/10.1007/s13300-025-01760-5
Citations
5
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
6.47

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion

Thomas Blevins, Johanna Ulloa, Mehrbod Vakhshoori, Kevin B. Kaiserman et al.
5 citations
Diabetes Therapy
Diabetes Management and Research
6.47
article

Safety and Efficacy of Inhaled Technosphere® Insulin in the Postprandial Period With Modified Initial Dose Conversion

Thomas Blevins, Johanna Ulloa, Mehrbod Vakhshoori, Kevin B. Kaiserman, Christopher Jacobson, Kevin Codorniz, Joanne Rinker, Pamela Lobo Moreno, Jennifer Pleitez, Joseph Sylvan, Scott Lee
article en
5 citations

Abstract

No abstract available for this paper.
Diabetes TherapyVol. 16(8)
Loma Linda University Medical Center (US), Loma Linda University (US), MannKind Corporation (United States) (US), Texas Diabetes & Endocrinology (US)
MannKind Corporation
Openalex Percentile: Top 3%
Diabetes Management and Research
6.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.